Treatment of liver steatosis and fibrosis with resmetirom- NEJM Feb 8, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis N Engl J Med 2024; 390:497-509 DOI: 10.1056/NEJMoa2309000 February 8, 2024
Blog
- Home
- Blog
-
09 MAR 24
- 0
-
-
09 MAR 24
- 0
Recently published: Cellular Oncology
Cellular Oncology https://doi.org/10.1007/s13402-023-00893-8 RESEARCH The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer Cristina Di Giorgio1 · Rachele Bellini1 · Antonio Lupia2,3 · Carmen Massa1 · Ginevra Urbani1 · Martina Bordoni1 · Silvia Marchianò1 · Rosalinda Rosselli4 · Rosa De Gregorio4 · Pasquale Rapacciuolo4 · Valentina Sepe4 · Elva Morretta5
-
-
08 MAR 24
- 0
Recently Published Hepatology 2023 Jul 1;78(1):26-44
Hepatology 2023 Jul 1;78(1):26-44. doi: 10.1002/hep.32787. Epub 2022 Oct 12. Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury Michele Biagioli 1, Silvia Marchianò 1, Cristina di Giorgio 1, Rosalinda Roselli 2, Martina Bordoni 1, Rachele Bellini 1,
-
Post più commentati